Clik here to view.
Fighting gravity: venture-backed biotech returns
I thought I’d tackle the question of what are the actual return distributions of venture capital investments in biotech startups (e.g., how many losers, how many winners) to set some context. As a...
View ArticleStarting a biotech? Advice for how to pitch VCs
Lots of great advice exists for tech entrepreneurs trying to pitch to VCs, but very little for the aspiring life science entrepreneur, especially for therapeutics startups. Since that’s the type of...
View ArticleFour Types of “Premature Scaling” in Biotech
Earlier this week the Startup Genome project released a report on the DNA of internet startups. Essentially what attributes lead to success or failure. One of the things they found was that 74% of...
View ArticleFinancing early stage biotech
I read Bruce Booth’s blog, Life Sci VC, when I get the chance, and he’s often lent his skills to Nature Biotechnology. We had him into our offices as part of our Meet the Author series, for example,...
View ArticleAssessing VC funding in biotech
Ever since Prospect Ventures handed back $150M of committed money to its limited partners, there has been plenty written on the lack of venture capital funding for the life sciences. However, a deeper...
View Article